Table 2.
Proportion of days utilizing analgesia and sedation
| 2010 | 2016 | Difference (95% CI) | p value | |
|---|---|---|---|---|
| Analgesia | ||||
| Overall | 23,854/52803 (45%) | 25,017/40612 (62%) | 0.164 (0.160 to 0.168) | < 0.001 |
| Europe | 11,472/22005 (52%) | 10,931/15592 (70%) | 0.180 (0.173 to 0.187) | < 0.001 |
| US/Canada | 2142/4984 (43%) | 1054/1993 (53%) | 0.099 (0.083 to 0.115) | < 0.001 |
| Asia | 3033/9335 (32%) | 4398/10096 (44%) | 0.111 (0.103 to 0.119) | < 0.001 |
| Africa | 254/869 (29%) | 499/912 (55%) | 0.255 (0.224 to 0.286) | < 0.001 |
| Australia/New Zealand | 1579/3094 (51%) | 533/672 (79%) | 0.283 (0.259 to 0.307) | < 0.001 |
| Latin America | 5374/12516 (43%) | 7602/11347 (67%) | 0.241 (0.233 to 0.249) | < 0.001 |
| Sedation | ||||
| Overall | 24,925/52803 (47%) | 23,520/40612 (58%) | 0.107 (0.102 to 0.112) | < 0.001 |
| Europe | 11,773/22005 (54%) | 10,468/15592 (67%) | 0.136 (0.129 to 0.143) | < 0.001 |
| US/Canada | 2439/4984 (49%) | 1030/1993 (52%) | 0.027 (0.008 to 0.046) | 0.003 |
| Asia | 3401/9335 (36%) | 4507/10096 (45%) | 0.082 (0.073 to 0.091) | < 0.001 |
| Africa | 281/869 (32%) | 500/912 (55%) | 0.225 (0.192 to 0.258) | < 0.001 |
| Australia/New Zealand | 2016/3094 (65%) | 577/672 (86%) | 0.207 (0.183 to 0.231) | < 0.001 |
| Latin America | 5015/12516 (40%) | 6438/11347 (57%) | 0.167 (0.158 to 0.176) | < 0.001 |